Introduction.-It has been shown that the animal microorganism, Tetrahymena, possesses a pattern for the metabolism of purines and pyrimidines which is at variance with other animals so far critically studied. Unlike higher animals, Tetrahymena has lost capacities for the synthesis of certain purines and pyrimidines. Thus it was shown' that of the naturally occurring purines only guanine would satisfy its requirement. Adenine and hypoxanthine are metabolized, however, since both show guanine sparing action. Xanthine was found to be, inactive. It was likewise shown that only uracil, of the naturally occurring pyrimidines, would satisfy the pyrimidine requirement of Tetrahymena. Unlike the purine specificity, however, a block occurs which makes it impossible for the organism to carry out the riboside linkage with cytosine, for either cytidine or cytidylic acid will replace uracil, uridine or uridylic acid.
By the use of a number of substituted purines2 and pyrimidines,3 it was possible to gain some information as to the specific metabolic abilities of this organism regarding these important classes of compounds. It was shown, for instance, that of the methyl-substituted xanthines all were inert or inhibitory with the single exception of 1-methyl xanthine. This latter compound would replace guanine with 15 per cent activity. Methyl substitutions on the guanine molecule reduced its activity for guanine replacement. 1-Methylguanine was 75 per cent as effective as guanine, and 7-methylguanine and 1,7-dimethylguanine were weakly active in sparing guanine. Any substitution on the uracil molecule reduced the activity to 1 per cent or less.
Inasmuch as the metabolic pathways for nucleic acid constitutents have assumed considerable importance, it is the purpose of this paper to report extensions of our previous findings and to compare briefly the biosynthetic abilities of Tetrahymena with those of other organisms.
Experimental.-Tetrahymena geleii W, grown in pure (bacteria-free) cultures, was used throughout this work. The basal medium used is given in table 1 . A new technique using the Brewer Automatic Pipetting Machine, described elsewhere,4 was used for accuracy and speed. Quantitative growth determinations were made turbidimetrically by use of a Lumetron photoelectric colorimeter with a red (650) filter. The tubes were incubated at 25°C. for 96 hours in a slanted position for adequate aeration.' All series were run in triplicate and the experiments repeated varying numbers of times.
Results.-The imidazole ring: It was earlier reported6 that Tetrahymena was able to synthesize guanine from 2,4-diamino-5-formylamino-6-hydroxy pyrimidine. The latter compound was said to possess 13.5 per cent activity when compared to guanine hydrochloride dihydrate on a weight basis. ments. Other samples of the formylamino pyrimidine, free of guanine contamination, had no activity for Tetrahymena either before or after hydrolysis. It is apparent, therefore, that this organism does not possess the necessary enzymes for the dehydration of 2,4-diamino-5-formylamino-6-hydroxy pyrimidine and is incapable of forming the imidazole ring. As might be expected, 2,4-diamino-5-acetylamino-6-hydroxy pyrimidine and 2,4-diamino-5-propionylamino-6-hydroxy pyrimidine were inert, as was 2,4,5-triamino-6-hydroxy pyrimidine.
Tetrahymena is able to demethylate position 8 of guanine to some extent (8-methyl guanine was 5 per cent as active as guanine), but 8-ethyl guanine7 iS inert. Release of the inhibition caused by 7-amino-1-v-triazolo(d)-pyrimidine (adenazolo) by adenine, but not by guanylic acid.
The amounts of guanylic acid and adenine are in y/ml. Guanine and hypoxanthine, like guanylic acid, do not release.
Triazolo analogs: It was previously reported2 that the triazolo analog of hypoxanthine (7-hydroxy-1-v-triazolo(d)pyrimidine) was not inhibitory to Tetrahymena within the ranges tested. This finding, when considered in relation to the activity of the adenine analog (7-amino-1-v-triazolo(d)-pyrimidine) to be considered below, assumes importance in evaluating the metabolism of hypoxanthine and adenine by this organism.
The adenine analog, which we shall call adenazolo in keeping with the previous nomenclature of these compounds,8 is an active purine inhibitor with an inhibition index (half maximum) of 5. This inhibition is specifically reversed by adenine. Guanine and hypoxanthine are inactive. A typical experiment is illustrated in Figure 1 showing the inability of guanine to re-verse the adenazolo inhibition. It is to be remembered that both hypoxanthine and adenine are active in sparing guanine, and it was suggested2 that hypoxanthine might be used by Tetrahymena for the synthesis of inosinic acid. It now appears more likely that the sparing action of hypoxanthine is due to its ready amination to adenine; when this system is blocked (by hypoxanthazolo), it is of little importance and no effect is noted. Dose respohse to pteroylglutamic acid (PGA) in media with and without thymine. The basal medium contained the following nucleic acid components in y/ml.: guanylic acid, 30; adenylic acid, 20; cytidylic acid, 25; uracil, 10. Under the conditions of these experiments half maximum growth in the medium devoid of thymine required approximately 0.00046 -y/ml. of PGA; with 10 ,y/ml. of thymine this requirement was reduced to 0.00035 -y/ml. and with 20 'y/ml. of thymine the requirement was further reduced to 0.00021 'y/ml. Raising the level of thymine up to 50 'y/ml. resulted in no greater sparing action than 20 -y/ml. of thymine.
Pyrimidines. Orotic acid: Inasmuch as orotic acid (4-carboxyuracil) has been found to have activity for certain pyrimidine-less Neurospora mutants9 10 (Fig. 2) which is taken to mean that PGA is active in one or more steps in the synthesis of thymine. ThymidinelH is approximately twice as active as thyrnine as a sparer of PGA, indicating that PGA may function also in performing the desoxyriboside linkage. These observations are in agreement with those on Lactobacillus casei516 and Streptococcus fecalis16"7 where thymine was found capable of replacing PGA. Tetrahymena differs from these bacteria, however, in that thymine and thymidine will only spare, never replace, PGA. One or more vital functions in the metabolism of this animal, in addition to those concerned with thymine and its desoxyriboside, are PGA controlled.
Discussion.-We can now reconstruct a probable course of metabolic pathways in Tetrahymena for purines and pyrimidines and compare these to what has been learned about these compounds in other organisms. Tetrahymena is shown by the requirement for guanine and the sparing action of adenine. Reaction 3 probably takes place in Tetrahymena. It may also take place in the four guanine-less mutants of the ascomycete Ophiostoma reported by Fries.22 '23 This reaction is blocked in the rat, as it was found that the administration of isotopically labeled guanine did not lead to the appearance of the isotope in the tissue purines.24 '25 Reaction 4 is blocked in Tetrahymena but may take place in the rat. Reaction 5 may take place in Tetrahymena but probably does not take place in the mammal, for if it did, in view of the apparent wide-spread ability of many or all organisms to aminate hypoxanthine to adenine, then dietary guanine would be converted to adenine via hypoxanthine. This appears to be precluded by the results of the tracer studies. Guanase activity occurs in the rat, but the result is xanthine, not hypoxanthine. Reaction 6 is blocked in Tetrahymena and the Ophiostoma mutants as evidenced by the fact that hypoxanthine will not replace guanine. Nothing is known about a xanthine oxidase (reactions 7 and 8) in Tetrahymena, although these are well-recognized reactions in many forms.
Reaction 9 is known to occur in Tetrahymena and the guanine-less Ophiotoma mutants22 28 but it probably does not occur in the rat, while reactions 10 and 11 certainly do occur in the mammal and reaction 10, at least, occurs in Tetrahymena. Reaction 12 takes placeinTetrahymena,and may also take place in the rat, while reaction 13 is blocked in Tetrahymena as shown by the fact that adenosine and adenylic acid are incapable of replacing guanine while guanosine and guanylic acid are fully active. PROC. N. A. S. tion 14 is not known to occur in Tetrahymena, but, inasmuch as inosinic acid will not meet the guanine requirement, reaction 15 is certainly blocked. Reactions 16 and 17 are known to occur in many organisms and probably take place in Tetrahymena, as indicated by the different results obtained when hypoxanthine and adenine inhibitors were employed. Figure 4 is a summary of the various steps in the metabolism of pyrimidines. Inasmuch as Mitchell, et al.,9" 10 have shown that certain pyrimidineless Neurospora mutants can use non-pyrimidine compounds and have suggested that ring closure does not precede the riboside linkage, we may suppose that at least three alternate routes of pyrimidine nucleoside synthesis developed in pre-animal systems. The first (reaction 1) is illustrated by the Neurospora mutants,9" 0 where it appears that oxaloacetic acid is converted to amino-fumaric acid and the riboside linkage completed before the pyrimidine ring is closed to form uridine. Whether these reactions are utilized to some degree in the rat is not known, but it is known that nitrogens 1 and 3 of the pyrimidine ring are derived from the ammonia pool'8 while carbon 2 is derived from C02.21 It seems clear from the; tracer studies of Arvidson, et. al.,'2 that orotic acid is utilized in the synthesis of uridine and is therefore synthesized from non-pyrimidine precursors (reaction 2). The interpretation placed upon these observations by Arvidson, et We take a directed set {a}, so that a < a, a < # and ( < y implies a < y, and to any a and (there is a 7ysuch that a < y and , < y; and we consider a family of spaces I R. } indexed by it, and for any a < , a map xe = pOX, from Rp, onto all of Ra, also called projection, such that for a < ( < y we have (ppVOy = 'Pa3 ("consistency"). In the direct product of all spaces Ra there is a "diagonal" set { X. } in whicb xa = poe for a < # and this is the so-called projective limit of the given inverse mapping system. ' The limit will be denoted by R or more explicitly by R,,., and we note that each point xa of every Ra is the a-th component of at least one point in R. The space could, but will not be appended to the given family by putting a < co, x. = 'oa , (IX,I).
We denote by Aa a set of subsets of each Ra, such that for Sa e Aa and a < , we have (,,p-l(S.) e AO. Each ' pa,r-(Sa) is a subset of R and the set of the latter subsets will be denoted by A or A,. If each Aa is a Boolean algebra then so is A itself,but if they are a-algebras then A need no longer be one. We assume that on each algebra Aa there is given a finitely additive measure ma, so that maRa = 1, and that they are consistent, m6[(a'-1(Sa)] = maSa. This gives rise to a such-like measure mS on A, m[,a'-1(Sa)I = maSa, but o-additivity need no longer reproduce itself. However the following theorem can be stated which for VOL. 36, 1950 
